Sacrosidase Pregnancy and Breastfeeding Warnings
Brand names: Sucraid
Medically reviewed by Drugs.com. Last updated on Sep 26, 2024.
Sacrosidase Pregnancy Warnings
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: C
Animal studies have not been conducted. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Sacrosidase Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation.
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
Comment: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2001) "Product Information. Sucraid (sacrosidase)." Orphan Medical
References for breastfeeding information
- (2001) "Product Information. Sucraid (sacrosidase)." Orphan Medical
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.